B
BLUE

Baird’s bluebird bio BLUE Stock Holding History

Baird’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$207K Buy
+133
New +$175K ﹤0.01% 1216

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Baird's BLUE Position: Q1 2015 in Review

Baird opened a new position in bluebird bio (BLUE) in Q1 2015: 133 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1216 among its holdings.

210 funds tracked by Wall St. Rank hold BLUE as of Q1 2015.

  • Baird held 133 shares of bluebird bio worth $207K as of Q1 2015.
  • bluebird bio was a new Baird position in Q1 2015.
  • bluebird bio made up ﹤0.01% of Baird's portfolio in Q1 2015, its #1216 holding.
  • 210 funds tracked by Wall St. Rank held bluebird bio as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.